©The Author(s) 2025.
World J Virol. Sep 25, 2025; 14(3): 108405
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.108405
Published online Sep 25, 2025. doi: 10.5501/wjv.v14.i3.108405
Table 2 Diagnostic techniques for Lassa fever
| Method | Type | Sample | Turnaround time | Advantages | Limitations |
| Reverse transcription PCR | Molecular | Blood or tissue | Few hours | Highly sensitive and specific; early detection | Requires specialized labs and trained personnel |
| ELISA (IgM, IgG, antigen) | Serological | Serum or plasma | 1-2 days | Useful for acute and retrospective diagnosis | Limited sensitivity in early stages |
| Virus isolation | Culture (definitive) | Blood or tissue | Several days | Confirmatory; research reference standard | Requires Biosafety Laboratory-4 facility; high biosafety risk |
| Next-generation sequencing | Genomic surveillance | Blood or tissue | Variable | Tracks evolution and strain diversity | Expensive and technology-intensive |
| Rapid diagnostic tests | Immunochromatography | Blood sample | 15-30 min | Fast, suitable for remote settings | Still under development and validation |
| Supportive laboratory indicators | Clinical chemistry | Blood, urine | Few hours | Suggestive (e.g., elevated aspartate aminotransferase, thrombocytopenia) | Not confirmatory; supportive only |
- Citation: Uppala PK, Karanam SK, Kandra NV, Edhi S. Lassa fever: A comprehensive review of virology, clinical management, and global health implications. World J Virol 2025; 14(3): 108405
- URL: https://www.wjgnet.com/2220-3249/full/v14/i3/108405.htm
- DOI: https://dx.doi.org/10.5501/wjv.v14.i3.108405